Company Data

bioAffinity Technologies Inc.

Ticker
BIAF
Current Price
$0.81 -3.57%
Market Cap
$12.6M
Price Target
Refer to Report
Volume
57.0K
52wk Range
$0.57 - $3.62
Advanced Market Data

Overview

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy